Enhance

Merck Agrees To Disclose Clinical Trial Delays

4 Comments

Merck Settles Shareholder Suit Over Enhance Trial

1 Comment

Another Vytorin Trial And Changing Endpoints

4 Comments

Schering-Plough Shareholders Win A Round In Court

7 Comments

Results Of Merck’s Vytorin Trial Delayed A Year

8 Comments

The Vytorin Limbo: How Low Can You Go?

6 Comments

Whytorin? Merck Cholesterol Pills Face Another Test

3 Comments

Grassley To NIH: Watch Those Academic Conflicts

10 Comments

The Trouble With Merck: One Analyst Turns Sour

29 Comments

Congress Miffed Over Vytorin Report & Consultant

4 Comments

Clear

Clear

All rights reserved, UBM Canon. Copyright, UBM Canon.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/